Concepedia

Emily A. Freeman

EA

Statistics

Publications

4

Citations

72

H-Index

4

Active since

2016

Affiliations

Kala Pharmaceuticals (United States)(Current)

Emily A. Freeman is an author at Kala Pharmaceuticals (United States) specializing in gamma secretase inhibition, neurodegenerative diseases, and alzheimer disease.

Publications per year

2016–2021

4

Publications

4

Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease

Matthew G. Bursavich, Bryce A. Harrison, Raksha Acharya et al. · Journal of Medicinal Chemistry · 2017 · 29 citations · Full text

, , +17

Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease

Jean‐François Blain, Matthew G. Bursavich, Emily A. Freeman et al. · Alzheimer s Research & Therapy · 2016 · 20 citations · Full text

, , +17

MEK1/2 activity modulates TREM2 cell surface recruitment

Jason Schapansky, Yelena Y. Grinberg, David M. Osiecki et al. · Journal of Biological Chemistry · 2020 · 13 citations · Full text

, , +17

Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator

Matthew G. Bursavich, Bryce A. Harrison, Raksha Acharya et al. · Journal of Medicinal Chemistry · 2021 · 10 citations · Full text

, , +17

1–4 of 4